Henry H. Le

Henry H. Le

Auto-generated profile, based on publicly available information

Henry H. Le

Cornell University

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2022 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
HLHenry H. Le
Henry H. Le
MLMin-Ting Lee
Min-Ting Lee
KBKevin R. Besler
Kevin R. Besler
JCJanine M. C. Comrie
Janine M. C. Comrie
EJElizabeth L. Johnson
Elizabeth L. Johnson
Consumption of dietary lipids, such as cholesterol, modulates the gut microbiome with consequences for host health through the production of microbiome-derived metabolites. Despite the implications for host metabolism, a limited number of specific interactions of the gut microbiome with diet-derived lipids have been characterized. This is partially because obtaining species-level resolution of the responsible taxa can be challenging and additional approaches are needed to identify health-relevant metabolites produced from cholesterol–microbiome interactions. Here we performed bio-orthogonal labelling sort sequence spectrometry, a click chemistry based workflow, to profile cholesterol-specific host–microbe interactions. Mice were exposed to an alkyne-functionalized variant of cholesterol and 16S ribosomal RNA gene amplicon sequencing of faecal samples identified diet-derived cholesterol-interacting microbes from the genera Bacteroides, Bifidobacterium, Enterococcus and Parabacteroides. Shotgun metagenomic analysis provided species-level resolution of diet-derived cholesterol-interacting microbes with enrichment of bile acid-like and sulfotransferase-like activities. Using untargeted metabolomics, we identify that cholesterol is converted to cholesterol sulfate in a Bacteroides-specific manner via the enzyme BT_0416. Mice monocolonized with Bacteroides thetaiotaomicron lacking Bt_0416 showed altered host cholesterol and cholesterol sulfate compared with wild-type mice, identifying a previously uncharacterized microbiome-transformation of cholesterol and a mechanism for microbiome-dependent contributions to host phenotype. Moreover, identification of a cholesterol-responsive sulfotransferase in Bacteroides suggests diet-dependent mechanisms for altering microbiome-specific cholesterol metabolism. Overall, our work identifies numerous cholesterol-interacting microbes with implications for more precise microbiome-conscious regulation of host cholesterol homeostasis.

1 October 2019 in Cell Reports
Verified
Journal Article
Open access
MLMichael J Lukey
Michael J Lukey
ACAhmad A. Cluntun
Ahmad A. Cluntun
WKWilliam P. Katt
William P. Katt
MLMiao-Chong J. Lin
Miao-Chong J. Lin
JDJoseph E. Druso
Joseph E. Druso
RCRichard Cerione
Richard Cerione
Efforts to target glutamine metabolism for cancer therapy have focused on the glutaminase isozyme GLS. The importance of the other isozyme, GLS2, in cancer has remained unclear, and it has been described as a tumor suppressor in some contexts. Here, we report that GLS2 is upregulated and essential in luminal-subtype breast tumors, which account for >70% of breast cancer incidence. We show that GLS2 expression is elevated by GATA3 in luminal-subtype cells but suppressed by promoter methylation in basal-subtype cells. Although luminal breast cancers resist GLS-selective inhibitors, we find that they can be targeted with a dual-GLS/GLS2 inhibitor. These results establish a critical role for GLS2 in mammary tumorigenesis and advance our understanding of how to target glutamine metabolism in cancer.

11 April 2016 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
JBJoshua A Baccile
Joshua A Baccile
JSJoseph E Spraker
Joseph E Spraker
HLHenry H Le
Henry H Le
EBEileen Brandenburger
Eileen Brandenburger
CGChristian Gomez
Christian Gomez
FSFrank C Schroeder
Frank C Schroeder
Analysis of orphan nonribosomal peptide synthetase–like gene clusters from Aspergillus fumigatus identified a gene cluster responsible for the biosynthesis of fumisoquin isoquinoline alkaloids by amino acid condensation and subsequent tailoring steps reminiscent of plant biosynthetic pathways. Natural product discovery efforts have focused primarily on microbial biosynthetic gene clusters (BGCs) containing large multimodular polyketide synthases and nonribosomal peptide synthetases; however, sequencing of fungal genomes has revealed a vast number of BGCs containing smaller NRPS-like genes of unknown biosynthetic function. Using comparative metabolomics, we show that a BGC in the human pathogen Aspergillus fumigatus named fsq, which contains an NRPS-like gene lacking a condensation domain, produces several new isoquinoline alkaloids known as the fumisoquins. These compounds derive from carbon-carbon bond formation between two amino acid–derived moieties followed by a sequence that is directly analogous to isoquinoline alkaloid biosynthesis in plants. Fumisoquin biosynthesis requires the N-methyltransferase FsqC and the FAD-dependent oxidase FsqB, which represent functional analogs of coclaurine N-methyltransferase and berberine bridge enzyme in plants. Our results show that BGCs containing incomplete NRPS modules may reveal new biosynthetic paradigms and suggest that plant-like isoquinoline biosynthesis occurs in diverse fungi.

1 December 2015 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
SSSimran S. Saund
Simran S. Saund
VSVictor Sosa
Victor Sosa
SHStephanie Henriquez
Stephanie Henriquez
QNQ. Nhu N. Nguyen
Q. Nhu N. Nguyen
CBChristopher L. Bianco
Christopher L. Bianco
JFJon M. Fukuto
Jon M. Fukuto

20 June 2022 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
SHStacey L. Heaver
Stacey L. Heaver
HLHenry H. Le
Henry H. Le
PTPeijun Tang
Peijun Tang
ABArnaud Baslé
Arnaud Baslé
CBClaudia Mirretta Barone
Claudia Mirretta Barone
RLRuth E. Ley
Ruth E. Ley
Inositol lipids are ubiquitous in eukaryotes and have finely tuned roles in cellular signalling and membrane homoeostasis. In Bacteria, however, inositol lipid production is relatively rare. Recently, the prominent human gut bacterium Bacteroides thetaiotaomicron (BT) was reported to produce inositol lipids and sphingolipids, but the pathways remain ambiguous and their prevalence unclear. Here, using genomic and biochemical approaches, we investigated the gene cluster for inositol lipid synthesis in BT using a previously undescribed strain with inducible control of sphingolipid synthesis. We characterized the biosynthetic pathway from myo-inositol-phosphate (MIP) synthesis to phosphoinositol dihydroceramide, determined the crystal structure of the recombinant BT MIP synthase enzyme and identified the phosphatase responsible for the conversion of bacterially-derived phosphatidylinositol phosphate (PIP-DAG) to phosphatidylinositol (PI-DAG). In vitro, loss of inositol lipid production altered BT capsule expression and antimicrobial peptide resistance. In vivo, loss of inositol lipids decreased bacterial fitness in a gnotobiotic mouse model. We identified a second putative, previously undescribed pathway for bacterial PI-DAG synthesis without a PIP-DAG intermediate, common in Prevotella. Our results indicate that inositol sphingolipid production is widespread in host-associated Bacteroidetes and has implications for symbiosis.

1 January 2021 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
MLMin-Ting Lee
Min-Ting Lee
HLHenry H. Le
Henry H. Le
EJElizabeth L. Johnson
Elizabeth L. Johnson
Min-Ting Lee, Henry H Le, Elizabeth L Johnson